Age-related macular degeneration (AMD):
In vitro and in vivo studies of viral-delivered antiangiogenic effectors for development of antiangiogenic medicines with the perspective of possible clinical translation of neovessel inhibition treatment based on viral gene transfer technology.
Development of gene medicines to restore imbalanced production of neuroprotective factors related to diabetic retinopathy.
Inherited eye diseases:
Development of gene therapy to treat vision loss due to inherited ocular disease.